BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15262897)

  • 1. CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice.
    Lin X; Ma X; Rodriguez M; Roos RP
    Int Immunol; 2004 Sep; 16(9):1237-40. PubMed ID: 15262897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative, not qualitative, differences in CD8(+) T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice.
    Lyman MA; Myoung J; Mohindru M; Kim BS
    Eur J Immunol; 2004 Oct; 34(10):2730-9. PubMed ID: 15368289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
    Pope JG; Karpus WJ; VanderLugt C; Miller SD
    J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis.
    Borrow P; Welsh CJ; Nash AA
    Immunology; 1993 Nov; 80(3):502-6. PubMed ID: 7904593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity.
    Lin X; Roos RP; Pease LR; Wettstein P; Rodriguez M
    J Immunol; 1999 Jan; 162(1):17-24. PubMed ID: 9886365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL; Olson JK
    J Immunol; 2009 Dec; 183(11):6971-80. PubMed ID: 19890055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.
    Mendez-Fernandez YV; Johnson AJ; Rodriguez M; Pease LR
    Eur J Immunol; 2003 Sep; 33(9):2501-10. PubMed ID: 12938226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology.
    Begolka WS; Haynes LM; Olson JK; Padilla J; Neville KL; Dal Canto M; Palma J; Kim BS; Miller SD
    J Neurovirol; 2001 Oct; 7(5):409-20. PubMed ID: 11582513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theiler's virus infection chronically alters seizure susceptibility.
    Stewart KA; Wilcox KS; Fujinami RS; White HS
    Epilepsia; 2010 Aug; 51(8):1418-28. PubMed ID: 20002148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells.
    Kang BS; Palma JP; Lyman MA; Dal Canto M; Kim BS
    Virology; 2005 Sep; 340(1):84-94. PubMed ID: 16039687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice.
    Nicholson SM; Dal Canto MC; Miller SD; Melvold RW
    J Immunol; 1996 Feb; 156(3):1276-83. PubMed ID: 8558008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M; Ohara Y
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance between persistent virus infection and immune cells determines demyelination.
    Rodriguez M; Pavelko KD; Njenga MK; Logan WC; Wettstein PJ
    J Immunol; 1996 Dec; 157(12):5699-709. PubMed ID: 8955224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in avidity and epitope recognition of CD8(+) T cells infiltrating the central nervous systems of SJL/J mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus.
    Kang BS; Lyman MA; Kim BS
    J Virol; 2002 Nov; 76(22):11780-4. PubMed ID: 12388742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease.
    Kim BS; Mohindru M; Kang B; Kang HS; Palma JP
    J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis.
    Murray PD; Pavelko KD; Leibowitz J; Lin X; Rodriguez M
    J Virol; 1998 Sep; 72(9):7320-9. PubMed ID: 9696828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis.
    Rodriguez M; Rivera-Quinones C; Murray PD; Kariuki Njenga M; Wettstein PJ; Mak T
    J Neurovirol; 1997 May; 3 Suppl 1():S43-5. PubMed ID: 9179791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.